Safety Study of X-82 in Patients With Advanced Solid Tumors
The purpose of this study is to determine the maximum tolerated dose (MTD) of X-82 as a single agent.
Advanced Solid Tumors
DRUG: X-82
Maximum Tolerated Dose, To determine the maximum tolerated dose (MTD) of X-82 as a single agent., 12 months
Preliminary Pharmacokinetics of X-82 given as a single agent, To characterize the preliminary pharmacokinetics (PK) of X-82 given as a single agent., 12 months|Preliminary biological activity, To explore the preliminary biological activity and clinical tumor response after treatment with X-82 given as a single agent., 18 months
The purpose of this study is to determine the maximum tolerated dose (MTD) of X-82 as a single agent.